Unda 23 (Seroyal USA)


Welcome to the PulseAid listing for the Unda 23 drug offered from Seroyal USA. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Seroyal USA
NON-PROPRIETARY NAME: Equisetum arvense, Hypericum perforatum, Nux vomica, Quercus robur, Tormentilla,
SUBSTANCE NAME: STRYCHNOS NUX-VOMICA SEED; QUERCUS ROBUR TWIG BARK; EQUISETUM ARVENSE BRANCH; HYPERICUM PERFORATUM; POTENTILLA ERECTA ROOT
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-12-14
END MARKETING DATE: 0000-00-00


Unda 23 HUMAN OTC DRUG Details:

Item DescriptionUnda 23 from Seroyal USA
LABELER NAME: Seroyal USA
DEA SCHEDULE:
ACTIVE STRENGTH: 6; 6; 5; 5; 6([hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL)
START MARKETING DATE: 2015-12-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 62106-1122_26e6ed42-2104-5968-e054-00144ff88e88
PRODUCT NDC: 62106-1122
APPLICATION NUMBER:

Other STRYCHNOS NUX-VOMICA SEED; QUERCUS ROBUR TWIG BARK; EQUISETUM ARVENSE BRANCH; HYPERICUM PERFORATUM; POTENTILLA ERECTA ROOT Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Seroyal USAUnda 23